1. Home
  2. WEAV vs REPL Comparison

WEAV vs REPL Comparison

Compare WEAV & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • REPL
  • Stock Information
  • Founded
  • WEAV 2011
  • REPL 2015
  • Country
  • WEAV United States
  • REPL United States
  • Employees
  • WEAV N/A
  • REPL N/A
  • Industry
  • WEAV EDP Services
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEAV Technology
  • REPL Health Care
  • Exchange
  • WEAV Nasdaq
  • REPL Nasdaq
  • Market Cap
  • WEAV 600.1M
  • REPL 547.0M
  • IPO Year
  • WEAV 2021
  • REPL 2018
  • Fundamental
  • Price
  • WEAV $6.43
  • REPL $8.55
  • Analyst Decision
  • WEAV Strong Buy
  • REPL Buy
  • Analyst Count
  • WEAV 5
  • REPL 9
  • Target Price
  • WEAV $12.20
  • REPL $12.00
  • AVG Volume (30 Days)
  • WEAV 1.3M
  • REPL 8.7M
  • Earning Date
  • WEAV 10-30-2025
  • REPL 11-06-2025
  • Dividend Yield
  • WEAV N/A
  • REPL N/A
  • EPS Growth
  • WEAV N/A
  • REPL N/A
  • EPS
  • WEAV N/A
  • REPL N/A
  • Revenue
  • WEAV $229,790,000.00
  • REPL N/A
  • Revenue This Year
  • WEAV $19.19
  • REPL N/A
  • Revenue Next Year
  • WEAV $15.09
  • REPL N/A
  • P/E Ratio
  • WEAV N/A
  • REPL N/A
  • Revenue Growth
  • WEAV 17.34
  • REPL N/A
  • 52 Week Low
  • WEAV $6.29
  • REPL $2.68
  • 52 Week High
  • WEAV $17.63
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 42.76
  • REPL 58.06
  • Support Level
  • WEAV $6.41
  • REPL $8.26
  • Resistance Level
  • WEAV $7.51
  • REPL $10.85
  • Average True Range (ATR)
  • WEAV 0.34
  • REPL 0.75
  • MACD
  • WEAV -0.01
  • REPL -0.12
  • Stochastic Oscillator
  • WEAV 11.84
  • REPL 25.79

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: